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HIV and other lentiviruses can productively infect nondividing cells, whereas most other retroviruses, such as murine
leukemia virus, require cell division for efficient infection. However, the determinants for this phenotype have been
controversial. Here, we show that HIV-1 capsid (CA) is involved in facilitating HIV infection of nondividing cells because
amino acid changes on CA severely disrupt the cell-cycle independence of HIV. One mutant in the N-terminal domain of
CA in particular has lost the cell-cycle independence in all cells tested, including primary macrophages. The defect in
this mutant appears to be at a stage past nuclear entry. We also find that the loss of cell-cycle independence can be
cell-type specific, which suggests that a cellular factor affects the ability of HIV to infect nondividing cells. Our data
suggest that CA is directly involved at some step in the viral life cycle that is important for infection of nondividing
cells.
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Introduction
One of the properties that set HIV-1 and other lentiviruses
apart from most of the other retroviruses is the ability to
infect cells independent of the cell cycle [1,2]. This ability
allows HIV-1 to propagate in nondividing cells in vivo such as
resting CD4þ T cells [3] and terminally differentiated
macrophages [4]. On the other hand, other retroviruses, such
as murine leukemia virus (MLV), require cell-cycle progres-
sion to achieve productive infection [5,6].
There has been considerable controversy over the deter-
minants of HIV infectivity in nondividing cells, with most
studies concentrating on presumed determinants for nuclear
import [2,7]. However, we recently showed that none of the
previously identiﬁed karyophilic elements in the HIV genome
are necessary for HIV to infect nondividing cells [8]. Rather,
we demonstrated that the retroviral capsid (CA) protein is a
major determinant for retrovirus infection in nondividing
cells because an HIV-based chimeric virus with MLV CA does
not infect nondividing cells [8]. Nonetheless, it was not clear
whether or not HIV CA was required to infect nondividing
cells, or whether we had transferred a negative regulator of
nuclear entry from MLV onto HIV. The present study was
designed to determine whether HIV CA plays a direct role in
the ability of this virus to infect nondividing cells.
The CA protein is a major structural protein that
constitutes viral cores, and also plays a role in the early
stages of infection (reviewed in [9]). Soon after virus entry
into the target cell, incoming virions disassemble their cores
in the cytoplasm (uncoating). However, it is not well under-
stood exactly how the uncoating process takes place in
acutely infected cells and which cellular factors may be
involved [10,11]. Moreover, the uncoating steps may be
different between HIV and MLV since most of the CA
proteins of HIV dissociate from nucleoprotein complexes of
incoming virions [10–17], whereas a large amount of CA
remains bound to intracellular complexes of MLV after
infection [18–20]. Therefore, one plausible hypothesis is that
the difference in the uncoating process may inﬂuence the fate
of retrovirus infection in nondividing cells by affecting
further downstream events (nuclear import and integration)
[21].
Here, we show that mutations in HIV CA can speciﬁcally
reduce the infectivity of HIV in nondividing cells, and
recapitulate the need for cell-cycle progression as seen for
MLV. Furthermore, cell-cycle independence of most of the
mutants is lost only in a particular cell type, which suggests
that a cellular factor limits their replication in nondividing
cells. We show that reverse transcription and nuclear import
of these mutants proceed normally in nondividing cells.
Finally, we show that, contrary to expectations, the kinetics of
uncoating of the bulk of CA from the incoming virus cores
does not correlate with the ability to infect nondividing cells.
However, a functional assay for CA association with the
reverse transcriptase complex (RTC) suggests that prolonged
association of some CA with the RTC is associated with a loss
of cell-cycle independence. These results suggest a direct role
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nondividing cells.
Results
Mutations in CA That Decrease the Ability of HIV-1 to
Infect Nondividing Cells
A panel of HIV CA mutations was created and tested for
their ability to infect nondividing cells (Table 1). These
mutations were introduced in amino acids exposed on the
surface of CA that had been previously characterized as
mutations that did not have severe effects on virus assembly
or budding, but decreased viral infectivity [22]. We intro-
duced each mutation onto an HIV-1 provirus with a deletion
in envelope (i.e., a single-round vector) that encodes either
luciferase or green ﬂuorescent protein (GFP) in place of the
nef gene [21]. In our initial screen for infection of non-
dividing cells, we arrested HeLa cells in S-phase by addition
of aphidicolin to the culture. As expected, the titer of MLV,
which requires cell-cycle progression for productive infec-
tion, was reduced by 50-fold in nondividing cells relative to
dividing cells, while infectivity of wild-type (WT) HIV-1 is
equivalent in both dividing and nondividing cells (Figure 1A;
Table 1). In contrast, CA mutants (T54A/N57A and Q63A/
Q67A) were reduced in nondividing cells compared to
dividing cells by 5- to 10-fold (Figure 1A; Table 1). The
reduced infectivity of these CA mutants in nondividing cells
is independent of multiplicity of infection, as the reduction
in infectivity can be observed over a 3-log range of viral input
(Figure 1A).
The decreased infectivity of the CA mutants in nondividing
cells is more severe than previously characterized mutations
in the vpr gene and the central polypurine tract [8], which had
little effect on the ability of HIV to infect nondividing cells
(Table 1). Importantly, the reduction of virus infectivity by
itself does not necessarily cause the defect in the cell-cycle
independence for infection, because some CA mutants that
exhibit reduced overall infectivity still maintain the same
property to infect nondividing cells as efﬁciently as dividing
cells (for example, the P38A and K70A mutations; Figure 1A).
In total, ﬁve separate mutants (E45A, T54A/N57A, Q63A/
Q67A, L136D, and Q219A) were identiﬁed that exhibit at
least a 4-fold decrease in the ability to infect nondividing cells
(Table 1).
We also infected monocyte-derived macrophages (MDMs),
a nondividing cell type that is a natural target of HIV
infection. Viruses were ﬁrst normalized for infectivity by
titrating them on MT4 cells and equivalent MT4 cell
infectious doses were used to infect macrophages. Figure 1B
shows representative ﬂow cytometry data showing that one of
the mutants, T54A/N57A, is indeed very defective in non-
dividing macrophages. Namely, while infectivity of WT HIV-1
in MDMs (17%) was basically similar to that in MT4 cells
(23%), the infectivity of T54A/N57A in MDMs (1.2%) was
much lower than in MT4 cells (44%), as shown in Figure 1B.
Interestingly, the Q63A/Q67A mutant is affected only
slightly in nondividing MDMs (Figure 1B). Thus, we also
tested the ability of CA mutants to infect another cell line,
HOS cells, that were dividing or nondividing. We found that
the T54A/N57A mutant could not infect nondividing HOS
cells, although it could infect dividing HOS cells (Figure 1C).
However, the Q63A/Q67A mutant (Figure 1C) and all of the
other CA mutants other than T54A/N57A (not shown) could
infect nondividing HOS cells just as well as it could infect
dividing HOS cells. These results indicate that there is cell-
type speciﬁcity to the ability of most of the mutants to infect
nondividing cells. Therefore, these ﬁndings suggest the
presence of cellular factors that differentially regulate virus
infectivity in non-cycling cells, but point to T54A/N57A as a
region of CA that is important for infection of nondividing
cells in diverse cell types.
Passage through Mitosis Alleviates Replication Block of
HIV CA Mutants
MLV can only infect cells that pass through mitosis [5,6]. We
asked if the HIV CA mutants that failed to infect nondividing
cells had a requirement for mitosis similar to MLV. To
determineif thereis a cell-cycle stage necessary for productive
transduction, we adapted a previously described method that
does not involve an artiﬁcial block of the cell cycle [23].
Actively cycling cells were infected with retroviruses carrying
Table 1. HIV Mutants Tested for Their Ability to Infect
Nondividing Cells
Virus Location in
CA Structure
Infectivity in Nondividing Cells
Relative to Dividing Cells (%)
a
HIV WT NA 84.4 6 22.9
HIVDcPPT NA 98.8 6 28.8
HIVDVpr NA 58.1 6 12.8
MLV NA 3.39 6 1.07
P38A Helix 2 103 6 6.00
E45A Helix 2 17.7 6 7.97
T54A/N57A Helix 3 9.58 6 2.08
Q63A/Q67A Helix 4 16.8 6 5.27
K70A Helix 4 134 6 36.8
E71A Helix 4 70.1 6 10.6
E128A/R132A Helix 7 163 6 21.9
L136D Helix 7 23.7 6 9.45
R143A Helix 7 91.1 6 30.5
Q219A Helix 11 24.9 6 5.40
aDividing and nondividing cells were infected with virus stocks that transduce 5% to 25%
of the cells to GFP-positivity by 2 d after infection. Infectivity in nondividing cells is shown
as a percentage of infectivity in dividing cells. The data used here is the average of three
independent infection experiments with standard deviations among those three
experiments.
NA, not applicable.
doi:10.1371/journal.ppat.0030156.t001
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Author Summary
HIV and related viruses are unusual among retroviruses in their
ability to replicate independently of cell-cycle progression of target
cells. However, the determinants of this phenotype have been
controversial. Here, we identified mutations on the surface of the
capsid (CA) protein that reduce the ability of HIV to infect
nondividing cells. These mutations also confer cell-cycle depend-
ency on HIV, even in dividing cells. Interestingly, some CA mutants
lose cell-cycle independence only in certain cell types. Thus, these
findings suggest that a cellular factor targeting CA regulates HIV-1
infection in nondividing cells. Surprisingly, these mutations do not
appear to affect nuclear localization of viral genomes, which points
to a novel regulation of the cell-cycle independence of HIV by the
CA protein.the GFP gene, harvested at different time points after
infection, and stained for DNA content with propidium
iodide. Cell-cycle analysis of GFP-positive cells (i.e., cells that
were successfully transduced with each GFP reporter virus)
early after infection revealed that the cell-cycle status of GFP-
positive cells in the MLV-infected cell population changes
dramatically at different time points after infection, while the
cell-cycle status of GFP-positive cells in the HIV-infected cell
population remains relatively stable over time (Figure 2). This
is likely due to the fact that MLV-transduced cells appear to
be synchronized in the cell cycle, because the only transduced
cells will be those that have passed through mitosis within a
narrow time window after infection. On the other hand, HIV
can transduce cells at any stage of the cell cycle, so HIV-
transduced cells always appear asynchronous in the cell cycle.
Speciﬁcally, most of the GFP-positive cells in the MLV-
infected cell population were in S-phase 15 h after infection.
These GFP-positive cells in MLV-infected cells were in late S-
phase 17.5 h after infection, by 20 h they were in G2/M phase,
and they completed mitosis from 20 to 22 h post infection
(indicated by arrow, Figure 2A, middle). In contrast, GFP-
positive cells in the HIV-infected cell population remain
asynchronous in their cell-cycle proﬁle at all time points post
infection (Figure 2A, left).
We tested two CA mutants, T54A/N57A and Q63A/Q67A, in
this assay, and found that cells infected with the HIV-1 CA
mutant Q63A/Q67A are nearly indistinguishable from MLV
in that they also are in S-phase at 15 h after infection and pass
from G2/M to G1 between 20 and 22 h after infection (Figure
2A, right; the transition from G2/M to G1 is indicated by an
arrow). We also obtained similar data using another CA
mutant (T54A/N57A, Figure 2B). Therefore, these two CA
mutants must have cell-cycle requirements for transduction
similar to MLV and different from WT HIV. These results
suggest that HIV CA mutants that fail to infect nondividing
cells, can, like MLV, productively infect cycling cells only
after they have passed through mitosis.
Replication of CA Mutants Was Blocked after Reverse
Transcription in Interphase Cells
We concentrated our mechanistic studies on the T54/N57A
mutant because it had the strongest defect in nondividing
cells (Table 1), and because it was affected in all cell types
tested (Figure 1). There are ample precedents for mutations
in CA that affect reverse transcription [24–30]. Thus, we were
interested in knowing whether this mutant had a defect
before or after reverse transcription. We therefore used a
real-time PCR assay to compare late products of reverse
transcription [31] for this mutant compared to those of WT
HIV in dividing and nondividing cells. Remarkably, even
though the amount of transduction (measured by GFP
expression) is reduced to 5% to 10% of the levels of dividing
Figure 1. HIV CA Mutants Require Cell Division for Efficient Infection
(A) Dose-independent restriction of several CA mutants in nondividing
cells. Nondividing cells were prepared by treatment of HeLa cells with
aphidicolin and then infected with increasing amount of GFP-encoding
viruses. Virus infectivity was measured by quantifying GFP-positive cells 2
d after infection. WT HIV-1 and MLV were used as controls. Open circles
indicate infections with cycling cells and closed circles indicate infections
with nondividing cells.
(B) Infection of MDMs with HIV-1. The WT strains together with CA
mutants T54A/N57A and Q63A/67A were used to infect a human T cell
line (MT4: upper panels) or MDMs (lower panels). Ten times more virus
was used in MDMs, which are not as permissive as MT4 cells to HIV-1
infection. Expression of GFP, which is encoded by the reporter virus
constructs, was examined 2 or 3 d after infection. The % of GFP-positive
cells is indicated in the upper half of each flow cytometry panel. The data
are representative of three independent experiments using at least three
different donor PBMCs.
(C) Viral infectivity of CA mutants in HOS cells. Cell-cycle requirement for
virus infection was examined by infectivity in dividing and nondividing
HOS cells with WT or CA mutants encoding the GFP gene. Nondividing
cells were prepared by treatment of aphidicolin (2 lg per ml) and the
chemical was added throughout the experiment. Open circles indicate
infections with cycling cells and closed circles indicate infections with
nondividing cells. Shown here are the data that represent at least two
independent experiments.
doi:10.1371/journal.ppat.0030156.g001
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not have a defect in synthesizing reverse transcription
products in nondividing cells. Although we saw a slight
decrease in the amount of the late reverse transcription
products by T54A/N57A in nondividing cells, the same degree
of reduction was also observed for WT HIV. Thus, we
conclude that the replication defect of this CA mutant in
nondividing cells occurs after reverse transcription.
Another hypothesis to explain why this CA mutant fails to
infect nondividing cells is that viral DNA of these mutants is
blocked from entering the nucleus before mitosis. Therefore,
we investigated nuclear entry by measuring the copy number
of 2-LTR circles, a marker of nuclear entry of viral genomes
(Figure 3A), and by cell fractionation (Figure 3B). We found
very little change in the formation of 2-LTR circles by T54A/
N57A in nondividing cells. Although we saw a slight drop of
2-LTR in nondividing cells compared with dividing cells (2.5-
fold), this amount of decrease is not likely to explain the
reduced infectivity in nondividing cells (19-fold decrease
from the infectivity in dividing cells). We obtained substan-
tially similar data for another CA mutant (E45A).
Nuclear entry of viral DNA was also examined by
subcellular fractionation followed by real-time PCR for
quantiﬁcation of reverse transcription products. Our cell
fractionation protocol was veriﬁed by showing that cytoplas-
mic protein, LDH-1, contaminated the nuclear fraction to
less than 4% (Figure 3B, top right), and a nuclear protein,
lamin B, could not be detected in the cytoplasmic fraction
(Figure 3B, bottom right). Using this assay we found that 70%
of the viral DNA of the CA mutant T54A/N57A was associated
with the nuclear fraction (Figure 3B). More importantly, the
amount of viral DNA associated with the nuclear fraction is
similar between WT and T54A/N57A (Figure 3B). Finally, we
looked at the localization of the 2-LTR circles in these
fractions, and found that in both WT and the T54/N57A
mutant, the 2-LTR circles were more abundant in the nuclear
fraction than in the cytoplasmic fractions in aphidicolin-
treated cells (Figure 3C). These results suggest this CA mutant
has the ability to access the nucleus in nondividing cells, and
the block to this mutant in nondividing cells may be at a stage
post–nuclear entry.
Uncoating of CA Mutants
We previously hypothesized that uncoating of the viral core
might be the rate-limiting step for the ability of a retrovirus
to infect non-cycling cells [2]. Thus, we sought to examine the
uncoating of these CA mutants in vivo. We used a recently
developed assay [32] for in situ determination of the CA
association with intracellular viral complexes. Brieﬂy, virus is
labeled with GFP-Vpr [33] and the membrane is labeled by
Figure 2. HIV-1 CA Mutants Resemble MLV in Their Cell-Cycle Require-
ments for Transduction
HeLa cells were infected with GFP-encoding viruses HIV-1, MLV, and HIV-
1 CA mutants (A) Q63A/Q67A or (B) T54A/N57A. The cell-cycle profiles of
the GFP-positive populations of cells are shown. The y-axis in each plot is
the number of cells and the x-axis is the cell-cycle position and the
approximate positions of cells in G1 (left vertical line) and G2/M (right
vertical line) are indicated. HIV-1 in (A) carries the mutated vpr gene,
whereas the virus in (B) contains the intact vpr gene. The arrow indicates
the progression of the transduced populations infected with MLV or with
the HIV-1 CA mutants from G2/M to G1. Note that WT HIV remains
asynchronous in the cell cycle throughout the experiment.
doi:10.1371/journal.ppat.0030156.g002
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the N-terminal 15–amino acid sequence of c-Src (called S15-
Cherry) [32]. At various times after infection of HeLa cells,
the cells were ﬁxed and stained with an antibody to p24CA.
The total complexes that entered the cytoplasm (green spots
that lost the membrane dye) were counted, and the number of
complexes that contained p24 (not uncoated) was compared
to the number of complexes that lost p24 staining (uncoated).
The numbers are represented as the % of p24CA positive
cytoplasmic particles (Figure 4).
WT virus, as expected, began to lose CA soon after
infection (Figure 4, black line). By 1–2 h after infection,
about 50% of the intracellular complexes contained detect-
able CA, and by 4 h after infection, less than 30% contained
detectable CA. The kinetics of uncoating of the Q63A/Q67A
mutant proceeded, as predicted, more slowly than that of the
WT virus (Figure 4, red line). At 1 and 2 h afterwards, most of
the particles were positive for CA (Figure 4, middle). By 4 h
after infection, however, the number of particles that stained
positive for CA in the Q63A/Q67A mutant was about the
same as for WT virus. On the other hand, the cores associated
with the T54A/N57A CA mutant were uncoated more quickly
than the cores associated with WT CA at the early time points
post infection (Figure 4, blue line). While a similar association
of CA with intracellular viral complexes was detected at the 0-
h time point (immediately after infection); by 1 h after
infection, only about 20% of the complexes had detectable
CA. This proportion stayed about the same at 2 and 4 h
(Figure 4, blue line). These data demonstrate that a failure to
uncoat the bulk of CA from the RTC cannot explain the
inability of each of the CA mutants to infect nondividing
cells. Rather, it appears that at least one of the mutants
uncoats faster than WT virus.
In addition to the uncoating assay (Figure 4), we also used
another assay that takes advantage of the fact that interaction
of cyclophilin A (CypA) with viral CA enhances HIV-1
replication and that this enhancement is blocked by treat-
ment with cyclosporine A (CsA). Since the target of CypA is
the CA protein itself, we reasoned that the RTC would be
sensitive to the negative effects of CsA for the amount of time
that functional CA was associated with the RTC. Namely, the
longer CA is associated with RTC, the longer CsA inﬂuences
virus infectivity. We did this experiment in T cells that were
infected with virus with its own envelope (X4 envelope) in
Figure 3. Reverse Transcription and Nuclear Import of Viral DNA in
Nondividing Cells
(A) Viral DNA synthesis and formation of 2-LTR circles. Dividing (shown in
white bars) and nondividing HeLa cells (shown in black bars) prepared by
aphidicolin treatment were infected with reporter virus constructs
bearing the WT CA or T54A/N57A mutation. Virus infectivity was
assessed by quantifying GFP-positive cells 2 d after infection. Relative
infectivity is shown as percentage of infectivity in dividing cells. Total
DNA was extracted 1 d after infection and used in real-time PCR to
measure the copy number of late products of reverse transcription (RT)
as well as that of 2-LTR circles. The data is shown as relative values where
the amount in dividing cells for each different virus is set at 100%.
Infections were done in triplicate and error bars indicate standard
deviation. Two independent experiments were performed with similar
results. One representative experiment is shown here.
(B) Nuclear localization of viral DNA. Nondividing cells infected with
either WT HIV-1 or the CA mutant T54A/N57A were separated into
cytoplasmic and nuclear fractions (left panel). DNA extracted from each
fraction was used as template for real-time PCR to measure newly
synthesized viral DNA. The efficiency of nuclear migration of viral DNA
was examined by dividing the copy number of viral DNA in nuclear
fractions by that in both fractions (cytoplasmic plus nuclear fractions).
The data shown here is a representative of two independent experi-
ments; although the ratio of viral DNA associated with nuclear fractions
differed between two experiments, the amount of viral DNA associated
with nuclear fraction remains the same between WT and the CA mutant.
Controls with reverse transcriptase inhibitors showed that contamination
by plasmid DNA accounted for less than 1% of the values (not shown).
Western blotting analysis was performed to ensure the integrity of
subcellular fractionation (right panels). Contamination was checked by
checking a cytoplasmic protein, LDH-I (upper lanes) and a nuclar protein,
lamin B (lower lanes). To, total cell lysates; Cy, cytoplasmic extract; Nu,
nuclear lysates. Twenty migrograms of proteins were loaded on the gel
except for the following dilutions. Cytoplasmic extract was diluted by 5-
fold; 5-, 25-, and 125-fold dilutions correspond to lanes 4, 3, and 2 (upper
lanes).
(C) Subcellular localization of 2-LTR circles. Copy numbers of 2-LTR circles
in cytoplasmic (white boxes) and nuclear (black boxes) fractions were
measured by real-time PCR. The same fractions as in the (B) were used in
this PCR assay.
doi:10.1371/journal.ppat.0030156.g003
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virus.
A human T cell line, Jurkat cells, was infected with either
WT HIV-1 or T54A/N57A, both of which are based on
replication-competent viruses expressing luciferase. CsA was
added at different times after inoculation of virus to see how
long the effects of CsA on HIV-1 infection last. When the
drug was added simultaneously with the initiation of
infection of the viruses, WT HIV was moderately affected
by the treatment of CsA (;5-fold), whereas T54A/N57A was
more severely restricted (;25-fold) by the presence of the
drug (Figure 5A).
The kinetics of the sensitivity of the two viruses to CsA
appeared distinct. For WT virus, the sensitivity to CsA
inhibition rapidly declined within the ﬁrst few hours after
infection (Figure 5A), and the half-maximal effect of CsA was
seen at about 2 h. This result is in good agreement with the
uncoating as for WT in Figure 4. The effects of CsA on the
infection with T54A/N57A were more complex (Figure 5A).
There was an increased inhibition of virus infectivity when
CsA was added at 1 h after infection relative to when it was
added at the same time as the infection (Figure 5A). This
result was repeatable (N ¼ 3). However, after that initial
inhibition by CsA, there was a much slower gradual loss of
CsA sensitivity, and the half-maximal effect was not observed
until after 8 h.
As controls for the function of the RTC, we also measured
the kinetics of resistance to a reverse-transcriptase inhibitor,
nevaripine, and found that both WT and the T54A/N57A
mutant had an equivalent kinetic sensitivity with a 50%
maximal inhibition approximately 4 h after infection (Figure
5B). These results demonstrate that the T54A/N57A does not
affect the extent (Figure 3), or kinetics (Figure 4), of reverse
transcription. Nonetheless, the kinetics of CsA sensitivity of
this mutant suggest that functional association of CA with
infectious particles in T cells might occur with complex
kinetics that could have a major effect on downstream events
that are important for the ability to infect cells in a cell-cycle
independent fashion.
Discussion
Our previous study indicated that a chimeric HIV-1 having
MLV CA fails to infect nondividing cells [21]. This suggests
either that MLV CA negatively regulates virus infectivity in
nondividing cells or that HIV CA is an essential factor for
HIV infection of nondividing cells. Here, we provide direct
evidence that HIV-1 CA is an essential factor since we identify
mutations in CA that affect this process.
We previously proposed that inefﬁcient disassembly of the
viral core is responsible for the poor infectivity of MLV in
nondividing cells [9] since there appears to be a difference in
the amount of CA-associated MLV RTC and/or pre-integra-
tion complex (RTC/PIC) compared to that of HIV [14,19].
Thus, we expected mutants of HIV CA that failed to infect
nondividing cells also to uncoat CA from the RTC less slowly
than WT HIV. However, this does not seem to be the case
(Figure 4). One of the mutants, Q63A/Q67A, behaved this way
(Figure 4), but another mutant, T54A/N57A, appears to
uncoat more rapidly than WT HIV (Figure 4). Thus, there
appears to be no correlation between the uncoating of the
bulk of CA soon after infection and the ability to infect cells
independent of the cell cycle. It is also possible that CA
mutations indirectly affect the rate of reverse transcription,
which in turn could affect the composition of the PIC.
However, we found no difference in either the amount of
reverse transcription products made by the CA mutants
studied here (Figure 3), or more importantly, no difference in
the kinetics of completion of reverse transcription (Figure
5B).
However, all assays that look at total events soon after
infection have the caveat that it is not possible to distinguish
events leading to productive infection from events that are
dead-end products. Thus, we also adapted an assay previously
used to characterize CA association with RTC/PIC that relied
on the kinetic sensitivity of HIV to the Trim-CypA restriction
in owl monkey cells [34]. In this assay, only infectious events
are scored, because the ﬁnal read-out requires transcription
from the provirus. We wished to use this assay in human T
cells, and therefore relied on the kinetic sensitivity to
cylophilin enhancement (i.e., decreased infectivity in the
presence of CsA) rather than the restriction to Trim-CypA.
We found that there is a functional association of CA with the
RTC/PIC for several hours after infection (Figure 5) in Jurkat
T cells. In addition, one of the CA mutants (T54A/N57A) was
sensitive to CsA for a longer period of time than WT virus (on
the order of 8–10 h), suggesting that T54A/N57A may retain
some CA on the RTC for a longer period of time than WT
(Figure 5). In contrast, the in situ uncoating assay found that
this mutant uncoated faster than WT virus (Figure 4). Thus,
an alternative interpretation is that the in situ assays detect
the presence of an intact conical core structure, while the
CsA sensitivity of HIV infection detects another function that
Figure 4. In Situ Analysis of Kinetics of p24 Loss from Cytoplasmic HIV
HeLa cells were spinoculated with VSV-g pseudotyped, S15-mCherry,
GFP-Vpr labeled HIV-1DEnv virions for 2 h at 17 8C. Infection was
synchronized by washing off innocula and replaced with 37 8C media.
HeLa cells were then fixed and immunostained for p24
CA (Cy-5) at the
indicated time post infection and imaged. GFP (þ) pucnta were then
quantified and individually examined for the presence of mCherry and
Cy-5 (p24
CA) signal. The identity of the samples was blinded before the
experiment. The percentage of the total number of virions that have
stained for p24
CA over time following fusion is shown. The 0-h time point
represents total number of GFP (þ) virions that stained positive for p24
CA.
HIVWT is represented by black lines/circles, the Q63/67A CA mutant by
red line/diamonds, and the T54A/N57A CA mutant by blue line/triangles.
The results shown are from three independently performed experiments
and the standard deviation at each time point is shown.
doi:10.1371/journal.ppat.0030156.g004
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RTC for extended periods after uncoating. This could explain
the increased sensitivity of the T54A/N57A mutant to CsA
(Figure 5).
Another CA mutant (Q63A/Q67A) that lost the cell-cycle
independence for infection was found to contain more CA
proteins in the mature RTC in both the in situ uncoating
assay (Figure 4), and in an independent biochemical assay
[35]. These results support a model whereby some degree of
association of CA with the RTC/PIC prevents infection of
nondividing cells, and that total uncoating is the rate-limiting
step for efﬁcient infection of nondividing cells. Nonetheless,
other models for a role of CA in other early steps of the virus
life cycle that is important for cell-cycle independence
cannot be ruled out.
The mechanistic basis of uncoating is not well understood,
but the CA protein is the likely candidate for regulation of
core disassembly due to differential levels of its association
with intracellular virus complexes. Thus, it is possible that
substitution of certain amino acid residues in the CA may
alter the stability of virus cores and thus the kinetics of CA
disassembly from the viral core in infected cells. However the
cell-type speciﬁcity for the replication block of HIV CA
mutants in nondividing cells argues against this possibility; if
the intrinsic property of a virus by itself determines the
reduced infectivity, then we would not likely see any differ-
ence in viral infectivity between different cell types. Instead,
these data suggest the involvement of cellular factors in
regulating the role of incoming viral cores in target cells.
Both MLV and HIV CA mutants require progression of cell
cycle through mitosis for efﬁcient replication (Figure 2). The
long-held idea to explain the requirement of mitosis for
productive infection by MLV is that MLV lacks the ability to
transport its viral DNA into the nucleus across intact nuclear
envelope of interphase cells and that mitosis literally removes
this barrier of nuclear membrane because of nuclear
membrane breakdown during mitosis [6]. Consistent with
this idea, incorporation of tRNA has been implicated in the
role of nuclear transport of HIV, and is absent in MLV [36].
However, we found that viral DNA of CA mutants is
associated with the nucleus and results in the accumulation
of 2-LTR circles. Thus, our data suggest that the HIV CA
mutants only transduce cells that go through mitosis (Figure
2), but that nuclear import per se is not the limiting step.
Indeed, others have also shown that HIV-1 CA can affect a
post–nuclear entry step [35]. In addition, there is a report
suggesting that factors other than the nuclear membrane
govern the infectivity of MLV in nondividing cells (macro-
phages) [37]. Thus, while nuclear import of PICs is undoubt-
edly necessary during the viral life cycle, these data suggest
that there are steps past nuclear entry that may be critical
determinants for the ability to infect nondividing cells. The
direct implication of CA in the infection of nondividing cells
by HIV may help uncover novel means of disrupting this
critical pathway in the viral life cycle.
Materials and Methods
Cell culture. Cell lines were grown in DMEM supplemented with
either 10% calf serum or fetal bovine serum (FBS). MDMs were
prepared as described before [21] and cultured in RMPI with 10%
FBS and 5% human serum.
Viral constructs. The proviral DNA pLai is an infectious molecular
clone of HIV-1 [38]. Reporter virus constructs created based on pLai
and encoding either the luciferase gene or the EGFP gene in place of
the nef open reading frame were described previously (pLai3DEnv-
luc2 and pLai DEnv-GFP3, respectively) [21]. They lack a functional
envelope gene, allowing single-cycle replication assays by pseudotyp-
ing virions with envelope proteins supplied in trans. DNA fragment
encompassing the HIV-1 CA-encoding region was digested from pLai
with ApaI and BssHII and cloned into either pSL1180 or pBluescript
II, both of which were also processed with the same combination of
restriction enzymes. Point mutations were introduced in the plasmid
DNA containing a part of HIV-1 sequence by using a commercial
PCR mutagenesis kit. DNA constructs with a substitution were subject
to DNA sequencing to ensure that any unwanted change is not made
in the HIV-encoding fragment. DNA fragments encoding mutated CA
sequences were cloned into ApaI/BssHII-digested, HIV-based report-
er viruses (pLai3DEnv-luc2 and pLaiDEnv-GFP3). HIV mutant
reporter clones lacking the intact Vpr gene were created by
combining pLaiDEnv-GFP3 having the WT CA sequence or bearing
Figure 5. Kinetics of HIV-1 Sensitivity to CsA
(A) CsA affects HIV-1 with the CA mutation T54A/N57A much longer than
HIV-1 with WT CA. Human T cell Jurkat cells were infected with
replication-competent HIV-1 virus encoding the WT envelope and the
luciferase gene, which contains either the WT CA sequence or the T54A/
N57A mutation. CsA was added to the well at indicated time points. Virus
was added at 8 8C by spinolculation, and infections were synchronized
by washing off the innocula and adding media at 37 8C. The relative
percentage of infectivity was determined by assigning the luciferase
value of the sample without CsA as 100% for each virus. White circles
indicate WT, black circles the mutant (T54A/N57A). Similar results were
observed in three independent experiments.
(B) Reverse transcription (RT) of T54A/N57A progresses similarly to that
of WT. Similar experiments were done as above (A), except that
nevirapine (50 lM) was added instead of CsA.
doi:10.1371/journal.ppat.0030156.g005
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reported Vpr mutant [39].
Virus stocks. Virus stocks were prepared by transient transfection
of 293T cells with various combinations of DNA constructs. Trans-
fections were performed with a commercial liposome-based trans-
fection reagent (TransIT-LT1; Mirus). An expression vector of VSV G
protein, pL-VSV-G, was used to make pseudotyped virions [40]. HIV-
1 proviral DNA constructs encoding either luciferase or GFP were co-
transfected with pL-VSV-G. Virus stocks for MLV were prepared by
transfection of four DNA constructs: Gag-Pol vector, retroviral
transfer vector, pL-VSV-G, and a construct for Tat expression
(pCMV-tat: to allow efﬁcient expression of VSV-G, which is under
control of HIV-1 LTR promoter) [40]. Either pJK3 [40] or pCS2þmGP
[21] was used as Gag-Pol expression plasmid construct. For GFP-
encoding, MLV-based retroviral transfer vectors, either pLXCG or
pLXSG were used [41]. For luciferase-encoding, MLV-based retroviral
transfer vectors, pLNCluc was used [21]. Culture supernatant was
harvested 2 and 3 d post transfection. The supernatant was cleared of
cell debris by low-speed centrifugation and passed through 0.22-lm
ﬁlters. Aliquots of the ﬁltered supernatant were frozen at  80 8C.
Supernatant of the virus stocks that exhibit a low titer in infectivity
assay was concentrated by ultracentrifugation after low-speed spin
and ﬁltration. Concentrated viruses were also kept at 80 8C until use.
Infectivity assays. Infectivity of HIV CA mutants was compared
between dividing and nondividing cells by single-cycle replication
assays. Brieﬂy, dividing HeLa or HOS cells were seeded at 8310
5 per
well for 12-well plates or at 4 3 10
5 per well for 24-well plates 1 d
before infection. Nondividing cells were prepared by seeding three
times more cells than the protocol for dividing cells and by treatment
with 2 lg of aphidicolin per ml. The cells were infected with
increasing amounts of virus stocks in the presence of 20 lg of DEAE-
dextran per ml. Virus attachment was enhanced by spinoculation at
1,200g for 30 to 60 min at room temperature. Inoculated viruses were
washed away and fresh medium were added to the plates. Two days
after infection, infectivity was examined by enumerating GFP-
positive cells with ﬂuorescence-activated cell sorter for GFP-encoding
viruses or by measuring the luciferase activity in lysed cells for
luciferase-encoding viruses.
MDMs were infected with GFP-encoding virus stocks 9 to 10 d after
preparation along with MT4, a human T cell line, in the presence of
20 lg of DEAE-dextran per ml. We used ten times more virus inocula
for macrophage infection than for MT4 infection, as MDM is not as
permissive as MT4 to HIV-1 infections. Infected cells were analyzed
for GFP expression 2 to 3 d after infection.
Cell-cycle analysis of virus-infected cells. Experiments were based
on a previous publication [23] but modiﬁed. Six 6-well plates
containing one million HeLa cells per plate were prepared for each
virus 1 d prior to infection. Virus inocula were chosen so that GFP-
expressing cells will become 3% to 5% at 15 h after infection. Virus
internalization and hence initiation of infection was synchronized by
spinoculation at 1,200g for 30 min at 4 8Co r1 58C to prevent
endocytosis of attached virions. Infection was initiated by placing the
plates in humanized CO2 incubator at 37 8C. Cells were harvested at
different time points and ﬁxed with 1% paraformaldehyde in PBS
overnight. The cells were then permeablized with 70% EtOH in PBS
overnight and stained with 50 lg/ml of propidium iodide in the
presence of 180 U of RNase A at 37 8C for 30 min. Analysis of DNA
content and GFP expression was performed on a FACScalibur
instrument (Becton Dickinson) by using CellQuest Pro software
(Becton Dickinson). GFP ﬂuorescence was determined by ﬂuores-
cence emission at 530 nm in log ampliﬁcation after excitation at 488
nm. PI ﬂuorescence was measured with a ﬁlter that collects
ﬂuorescence above 590 nm. Doublets were excluded from the analysis
by using the PI ﬂuorescence area and the pulse width. Samples were
analyzed until at least 5,000 GFP-positive cells were collected.
Real-time PCR. Subcellular fractionation was performed as
described previously [8]. Genomic DNA was extracted from infected
cells by using the QIAamp DNA Blood Mini kit (Qiagen). Copy
numbers of viral DNA were measured by real-time PCR based on
previous reports with minor modiﬁcations [31].
Western blotting analysis. Western blotting analysis of lysates and
extracts obtained from subcellular fractionation was done as
described previously [8]. Transferred membranes were probed with
the following antibodies: mouse monoclonal anti-lamin B (101-B7;
Calbiochem); sheep antibody against LDH I (Cortex Biochem).
In situ uncoating assay. Virus was generated by cotransfecting 7.4
lg HIV-1Denv plasmids with WT CA or the CA mutants, 6.4 lg S15-
mCherry to stain the viral membrane [32], 4.2 lg VSV-g, and 0.5 lg
GFP-Vpr [33] to stain total viral particles into 10-cm plates of 293T
virus-producing cells using polyethylenimine (PEI) (MW 25000,
Polysciences). S15-mCherry is a ﬂuorescent fusion protein that
contains the 15 N-terminal amino acids of the cellular Src protein.
This 15–amino acid sequence possesses a myristoylation sequence
followed by a basic stretch of amino acids that is sufﬁcient to cause
membrane association and virion incorporation of the S15-mCherry
protein [32]. As this membrane label is lost following fusion, this
system can effectively discriminate between virions that have been
non-productively endocytosed by the target cells (S15þ, GfpVprþ)
from those that have productively entered the host cell cytoplasm
(S15 , GfpVprþ).
Virus was harvested 48 h post transfection and ﬁltered through a
0.22-lm ﬁlter. For infections, HeLa target cells were seeded on
ﬁbronectin-treated coverslips and spinoculated for 2 h at 17 8C in the
presence or absence of Baﬁlomycin A (Sigma). Baﬁlomycin A (BafA)
was prepared in DMSO and diluted to a ﬁnal concentration of 20 nm
in DMEM. Virus was then removed and replaced with 37 8C media in
the presence or absence of BafA, shifted to 37 8C, and ﬁxed at the
indicated time point post infection. HeLa cells on glass coverslips
were ﬁxed with 3.7% formaldehyde (Polysciences) in 0.1 M Pipes
buffer (pH 6.8). Coverslips were stained with anti-p24 mAb AG3.0
(NIH AIDS Research and Reference Reagent Program) in blocking
solution (10% normal donkey serum [Jackson ImmunoResearch
Laboratories], 0.1% Triton X-100, 0.01% NaN3) for 30 min at RT
for primary stain and secondarily stained with labeled Cy5 donkey
anti-mouse antibodies (Jackson ImmunoResearch Laboratories).
Coverslips were mounted on slides with Gel Mount (Biomedia).
Images were collected and deconvolved with a Deltavision micro-
scope and software (Applied Precision). Following deconvolution, the
number of GFP-positive virions was assessed at each time point and
each virion was individually inspected for punctate mCherry
ﬂuorescent signal and p24 Cy-5 signal.
Time-course experiments with CsA. Jurkat cells were seeded in 96-
well plates at 100,000 cells per well. Virus inocula that produce
approximately 100,000 relative light units in luciferase assays were
used to inoculate the cells. Infections were enhanced by addition of
20 lg of DEAE-dextran per ml and by a brief spinoculation. Virus-
containing medium was washed away and fresh medium was added at
the start of infection. CsA resuspended in DMSO was added at
various time points after infection. The infected cells were lysed in a
cell culture lysis buffer (Promega) at 48 h after infection and
luciferase activity of the lysates was measured using the Luciferase
Assay System (Promega).
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